WO2004015392A3 - Improved method to identify targeting molecules - Google Patents
Improved method to identify targeting molecules Download PDFInfo
- Publication number
- WO2004015392A3 WO2004015392A3 PCT/US2003/024994 US0324994W WO2004015392A3 WO 2004015392 A3 WO2004015392 A3 WO 2004015392A3 US 0324994 W US0324994 W US 0324994W WO 2004015392 A3 WO2004015392 A3 WO 2004015392A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- improved method
- kinetic
- structure activity
- peptides
- vivo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03785119A EP1542733A2 (en) | 2002-08-08 | 2003-08-08 | Improved method to identify targeting molecules |
AU2003264030A AU2003264030A1 (en) | 2002-08-08 | 2003-08-08 | Improved method to identify targeting molecules |
CA002494551A CA2494551A1 (en) | 2002-08-08 | 2003-08-08 | Improved method to identify targeting molecules |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40237202P | 2002-08-08 | 2002-08-08 | |
US60/402,372 | 2002-08-08 | ||
US74092703P | 2003-05-14 | 2003-05-14 | |
US60/740,927 | 2003-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004015392A2 WO2004015392A2 (en) | 2004-02-19 |
WO2004015392A3 true WO2004015392A3 (en) | 2004-07-29 |
Family
ID=31720595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/024994 WO2004015392A2 (en) | 2002-08-08 | 2003-08-08 | Improved method to identify targeting molecules |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1542733A2 (en) |
AU (1) | AU2003264030A1 (en) |
CA (1) | CA2494551A1 (en) |
WO (1) | WO2004015392A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004263458B2 (en) * | 2003-08-08 | 2010-06-24 | Actgen, Inc. | Polypeptides having brain-localizing activity and uses thereof |
US20090092583A1 (en) * | 2005-08-26 | 2009-04-09 | Makoto Sawada | Brain-localizing cells and uses thereof |
FR2957597A1 (en) * | 2010-03-17 | 2011-09-23 | Univ Picardie | SYNTHETIC CYCLOPEPTIDES, PROCESS FOR PREPARATION AND USES |
CN108484640B (en) * | 2018-05-22 | 2020-09-15 | 南京华威医药科技集团有限公司 | Anti-tumor apoptosis protein inhibitor |
WO2024042466A1 (en) * | 2022-08-22 | 2024-02-29 | University Of Tartu | Brain penetrating peptides and methods of use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684621A (en) * | 1984-11-21 | 1987-08-04 | Smithkline Beckman Corporation | Methods of producing vasodilation or antioxytocic activity |
US5622699A (en) * | 1995-09-11 | 1997-04-22 | La Jolla Cancer Research Foundation | Method of identifying molecules that home to a selected organ in vivo |
WO1998010795A2 (en) * | 1996-09-10 | 1998-03-19 | The Burnham Institute | Tumor homing molecules, conjugates derived therefrom, and methods of using same |
-
2003
- 2003-08-08 AU AU2003264030A patent/AU2003264030A1/en not_active Abandoned
- 2003-08-08 CA CA002494551A patent/CA2494551A1/en not_active Abandoned
- 2003-08-08 EP EP03785119A patent/EP1542733A2/en not_active Ceased
- 2003-08-08 WO PCT/US2003/024994 patent/WO2004015392A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684621A (en) * | 1984-11-21 | 1987-08-04 | Smithkline Beckman Corporation | Methods of producing vasodilation or antioxytocic activity |
US5622699A (en) * | 1995-09-11 | 1997-04-22 | La Jolla Cancer Research Foundation | Method of identifying molecules that home to a selected organ in vivo |
WO1998010795A2 (en) * | 1996-09-10 | 1998-03-19 | The Burnham Institute | Tumor homing molecules, conjugates derived therefrom, and methods of using same |
Also Published As
Publication number | Publication date |
---|---|
WO2004015392A2 (en) | 2004-02-19 |
AU2003264030A1 (en) | 2004-02-25 |
CA2494551A1 (en) | 2004-02-19 |
EP1542733A2 (en) | 2005-06-22 |
AU2003264030A8 (en) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR17C1062I1 (en) | ||
Pitteri et al. | Electron transfer ion/ion reactions in a three-dimensional quadrupole ion trap: reactions of doubly and triply protonated peptides with SO2• | |
Narjes et al. | A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease | |
Amalian et al. | MS/MS digital readout: analysis of binary information encoded in the monomer sequences of poly (triazole amide) s | |
Tabb et al. | Statistical characterization of ion trap tandem mass spectra from doubly charged tryptic peptides | |
Gidden et al. | Duplex formation and the onset of helicity in poly d (CG) n oligonucleotides in a solvent-free environment | |
GB2366800A (en) | Antibody molecules having specificity for human tumor necrosis factor alpha and use thereof | |
Blumberger et al. | Formamide hydrolysis in alkaline aqueous solution: insight from ab initio metadynamics calculations | |
GB0124317D0 (en) | Biological products | |
WO2004015392A3 (en) | Improved method to identify targeting molecules | |
Hilderbrand et al. | Exploring crown ethers as shift reagents for ion mobility spectrometry | |
WO2008033433A3 (en) | Computational music-tempo estimation | |
Cook et al. | Metastable atom-activated dissociation mass spectrometry of phosphorylated and sulfonated peptides in negative ion mode | |
Newton et al. | Gaseous apomyoglobin ion dissociation in a quadrupole ion trap:[M+ 2H] 2+-[M+ 21H] 21+ | |
WO2002018637A3 (en) | Diagnosis and treatment of prostate cancer | |
Park et al. | Ab initio studies on the catalytic mechanism of aspartic proteinases: nucleophilic versus general acid/general base mechanism | |
Chirot et al. | Statistical analysis of ion mobility spectrometry. I. Unbiased and guided replica-exchange molecular dynamics | |
Wendt et al. | Quantitative evaluation of noncovalent chorismate mutase-inhibitor binding by ESI-MS | |
GB0008419D0 (en) | A method for invitro molecular evolution of antibody function | |
Harsch et al. | Accurate and rapid modeling of iron–bleomycin-induced DNA damage using tethered duplex oligonucleotides and electrospray ionization ion trap mass spectrometric analysis | |
WO2005044087A3 (en) | Methods for the determination of protein three-dimensional structure employing hydrogen exchange analysis to refine computational structure prediction | |
van Der Rest et al. | Dissociation channel dependence on peptide size observed in electron capture dissociation of tryptic peptides | |
EP1796707A4 (en) | Peptides that selectively home to heart vasculature and related conjugates and methods | |
TW200516897A (en) | Architecture and method of multilayered DRM protection for multimedia service | |
WO2003006669A3 (en) | Efficient methods for assessing and validating candidate protein-based therapeutic molecules encoded by nucleic acid sequences of interest |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2494551 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003785119 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003785119 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWR | Wipo information: refused in national office |
Ref document number: 2003785119 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003785119 Country of ref document: EP |